Filter Specialty
Submit To The Journals


touchCONGRESS Webinar Progress in the management of EGFR-mutant NSCLC in 2020: Where are we now?

Watch leading lung cancer expert, Dr Roy Herbst, review the latest findings on the use of targeted agents and genotyping in EGFR-mutant non-small-cell lung cancer (NSCLC), from ASCO20 Virtual, 29–31 May 2020.

Learn More

touchCONGRESS Expert Interviews ASCO20 Virtual

Watch leading lung cancer experts from Europe, the USA and China discuss the latest data presented at ASCO20 Virtual, 29–31 May 2020 in EGFR-mutant non-small-cell lung cancer (NSCLC) and consider what the findings may mean for global and regional clinical practice.

Learn More
  • Touch Medical Media Limited, trading as Touch Medical Media, is a private limited company registered in England and Wales at The White House, Mill Road, Goring, Reading, England, RG8 9DD with registered number 08197142. © 2019 All rights reserved.

    touchONCOLOGY is for informational purposes and intended for healthcare professionals only. Its content should not be considered medical advice, diagnosis or treatment recommendations.